FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

4324211000001104: Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1885441000001119 Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1885451000001116 Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Is a Cefaclor 375mg modified-release tablets 14 tablet true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Is pack of Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) false Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has active ingredient Cefaclor false Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has active ingredient Cefaclor monohydrate false Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has AMP Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cefaclor true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has specific active ingredient Cefaclor monohydrate false Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has specific active ingredient Cefaclor monohydrate true Inferred relationship Existential restriction modifier
Cefaclor 375mg modified-release tablets (Kent Pharma (UK) Ltd) 14 tablet Has basis of strength substance Cefaclor true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start